2025 ISAKOS Biennial Congress ePoster
Short To Midterm Outcomes For Concomitant Hip Arthroscopy And Periacetabular Osteotomy
Ady Haim Kahana Rojkind, MD, Des Plaines, IL UNITED STATES
Elizabeth G. Walsh, BS, Des Plaines, Illinois UNITED STATES
Roger Quesada Jimenez, MD, Des Plaines, Illinois UNITED STATES
Benjamin D Kuhns, MD, MS, Des Plaines, Illinois UNITED STATES
Justin M. LaReau, MD
Benjamin G. Domb, MD, Des Plaines, Illinois UNITED STATES
American Hip Institute Research Foundation, Des Plaines, Illinois, UNITED STATES
FDA Status Cleared
Summary
Concomitant hip arthroscopy and periacetabular osteotomy is an effective procedure with durable short-term and mid-term outcomes.
ePosters will be available shortly before Congress
Abstract
Purpose
To present short-term and mid-term results of concomitant hip arthroscopy followed by PAO for the treatment of acetabular dysplasia and intra-articular pathology, and to evaluate the rates of achieving clinically relevant outcome thresholds. We hypothesized that there would be improvement in patient reported outcomes (PROs) and rates of achieving thresholds at both timepoints.
Methods
Two-year and minimum five-year outcome data from a prospectively maintained database were queried to identify patients who underwent concomitant primary hip arthroscopy and periacetabular osteotomy (PAO). PROs evaluated at both timepoints included the modified Harris Hip Score (mHHS), non-arthritic hip score (NAHS), hip outcome score sport-specific subscale (HOS-SSS), and international hip outcome tool 12 (iHOT12). Previously defined clinically meaningful thresholds were also assessed at both timepoints, including minimal clinically important difference (MCID), patient acceptable symptom state (PASS), and substantial clinical benefit (SCB).
Results
28 hips were included in this study. All PROs demonstrated significant improvement from the preoperative baseline to both the short-term and mid-term timepoints respectively (p<0.001). There was no significant difference between PROs at the short- and mid-term timepoints (p>0.05). When evaluating MCID, PASS, and SCB thresholds for PROs at the short- and mid-term, no significant difference was found between the two time points (p>0.05).
Conclusions
Concomitant hip arthroscopy and PAO is an effective procedure with durable short-term and mid-term outcomes. Patients displayed equivalent success of meeting clinically relevant thresholds at both timepoints.